04

2025.07

Implementing the Law on the Prevention and Treatment of Infectious Diseases Multiple New Provisions to Prevent and Mitigate Public Health Risks

20

2025.06

New Options for Drug-Resistant Tuberculosis Treatment: Interpretation of WHO Guidelines Recommended 6-Month and 9-Month Regimens

13

2025.05

Expert Consensus on All-Oral Short-Course Treatment for Drug-Resistant Tuberculosis and Its Interpretation

15

2025.04

Interpretation of the 6-Month Short-Course Regimen — Based on the WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment and Care

24

2025.03

World Tuberculosis Day 2025 – TB Prevention Knowledge Promotion

24

2025.02

Notice of the National Disease Control and Prevention Administration(NDCPA) on Organizing the 2025 World Tuberculosis Day Publicity Campaign Released

15

2025.01

Striving to Promote the Modernization of the Disease Control and Prevention System - Institutional Arrangements for Disease Control and Prevention at the 2025 National Health Work Conference

08

2024.12

Experts Propose New Pathway for TB Control: A Multifaceted Approach Centered on "Active Screening + Preventive Therapy" to Accelerate the End of TB

28

2024.11

Nine Departments Issue the National Tuberculosis Prevention and Control Plan (2024–2033)

29

2024.10

Interpretation of Core Data from the 2024 Global Tuberculosis Report

09

2024.09

WHO Releases New Guidelines for Preventive Treatment of Drug-Resistant Tuberculosis: Levofloxacin as a Key Regimen, Potentially Reducing 100,000 New Cases Annually

25

2024.08

WHO Updates Treatment Regimens for Drug-Resistant Tuberculosis: Balancing Shorter Treatment Duration and Improved Efficacy